Goldman Sachs
CMAX

Goldman Sachs’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Goldman Sachs’s Portfolio CMAX Stock Details CMAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33,800
Closed -$94.3K – 6214
2024
Q2 		$94.3K Buy
+33,800
New +$106K ﹤0.01% 5408
2024
Q1 		– Sell
-3,257
Closed -$48.7K – 6034
2023
Q4 		$48.7K Buy
3,257
+220
+7% +$9.13K ﹤0.01% 5378
2023
Q3 		$193K Sell
3,037
-2,638
-46% -$185K ﹤0.01% 5051
2023
Q2 		$530K Sell
5,675
-755
-12% -$66.5K ﹤0.01% 4718
2023
Q1 		$515K Buy
6,430
+4,081
+174% +$477K ﹤0.01% 4809
2022
Q4 		$257K Sell
2,349
-391
-14% -$58.5K ﹤0.01% 5209
2022
Q3 		$583K Buy
2,740
+1,047
+62% +$212K ﹤0.01% 4870
2022
Q2 		$184K Buy
1,693
+734
+77% +$126K ﹤0.01% 5673
2022
Q1 		$215K Buy
+959
New +$199K ﹤0.01% 5842

Other funds holding CMAX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Goldman Sachs's CMAX Position: Q3 2024 in Review

Goldman Sachs sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q3 2024, closing a stake of 33,800 shares — an estimated $94.3K sold.

Goldman Sachs first reported a position in CMAX in Q1 2022 and held it in 9 quarters. The position peaked at $583K in Q3 2022. 21 funds tracked by Wall St. Rank hold CMAX as of Q3 2024.

  • Goldman Sachs reported no remaining CareMax, Inc. Class A Common Stock position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 33,800 CareMax, Inc. Class A Common Stock shares in Q3 2024, an estimated $94.3K.
  • Goldman Sachs first reported a position in CareMax, Inc. Class A Common Stock in Q1 2022 and held it in 9 quarters.
  • Goldman Sachs's CareMax, Inc. Class A Common Stock position peaked at $583K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.